Vt. A.G. Young: Opioid Maker Endo Agrees to Up to $450M Settlement
August 18, 2022
August 18, 2022
MONTPELIER, Vermont, Aug. 18 -- Vermont Attorney General Susanne R. Young issued the following news release on Aug. 17, 2022:
The Vermont Attorney General's Office has reached an agreement in principle with opioid maker Endo over its role in promoting the opioid crisis. Endo, an Ireland-based drug maker with U.S. headquarters in Pennsylvania, makes generic and branded opioids, including Percocet and Endocet, and Opana ER, before it was withdrawn from the market in 2017. The set . . .
The Vermont Attorney General's Office has reached an agreement in principle with opioid maker Endo over its role in promoting the opioid crisis. Endo, an Ireland-based drug maker with U.S. headquarters in Pennsylvania, makes generic and branded opioids, including Percocet and Endocet, and Opana ER, before it was withdrawn from the market in 2017. The set . . .